HighGravityDataUnitedHealth Group — Jul 29, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-25-000228
Showing in the filing
Return to earnings growth
“return to earnings growth”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 77
Adjusted Net Earnings per Share (a) for FY2025
“At least $16.00”
Revenue Outlook for FY2025
“$445.5 Billion to $448.0 Billion”
Earnings Outlook (Diluted EPS) for FY2025
“at least $14.65 Per Share”
Return to earnings growth for FY2026
“return to earnings growth”
Total Optum Revenues for FY2025
“$266,000 - $267,500”
Eliminations - Revenue for FY2025
“($164,500) - ($165,000)”
Total UnitedHealth Group - Revenue for FY2025
“$445,500 - $448,000”
Diluted Net Earnings per Share for FY2025
“At least $14.65”
Medical cost ratio for FY2025
“89.25% +/- 25 basis points”
Operating cost ratio for FY2025
“12.75% +/- 25 basis points”
Quarterly dividend rate
“$2.21”
Employer & Individual Revenues for FY2025
“$79,600 - $80,100”
Medicare & Retirement Revenues for FY2025
“$170,200 - $170,700”
Community & State Revenues for FY2025
“$94,200 - $94,700”
Total UnitedHealthcare Revenue for FY2025
“$344,000 - $345,500”
UnitedHealthcare - Operating Earnings for FY2025
“$9,000 - $9,300”
UnitedHealthcare Operating Margin for FY2025
“2.6% - 2.7%”
Commercial Risk - Growth in People Served for FY2025
“(385)”
Commercial Risk - Total People Served for FY2025
“8,460”
Commercial Fee - Growth in People Served for FY2025
“720”
Commercial Fee - Total People Served for FY2025
“21,605”
Total Commercial - Growth in People Served for FY2025
“335”
Total Commercial - Total People Served for FY2025
“30,065”
Medicare Advantage - Growth in People Served for FY2025
“650”
Medicare Advantage - Total People Served for FY2025
“8,495”
Standardized Medicare Supplement - Growth in… for FY2025
“(50)”
Standardized Medicare Supplement - Total Peo… for FY2025
“4,285”
Medicaid - Growth in People Served for FY2025
“200”
Medicaid - Total People Served for FY2025
“7,635”
Total Medical - Growth in People Served for FY2025
“1,135”
Total Medical - Total People Served for FY2025
“50,480”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“(300)”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“2,750”
UnitedHealthcare revenues for FY2025
“$344.0 billion to $345.5 billion”
UnitedHealthcare earnings from operations for FY2025
“$9.0 billion to $9.3 billion”
People served with medical benefits, expecte… for FY2025
“up to 1.135 million”
People served with commercial benefits, expe… for FY2025
“up to 335,000”
Growth within self-funded employer-sponsored… for FY2025
“720,000”
People served with commercial insured offeri… for FY2025
“385,000”
Contraction in individual insured offerings for FY2025
“180,000”
Decline in employer-sponsored group products for FY2025
“205,000”
Medical cost trend in Medicare Advantage off… for FY2025
“~7.5%”
Pricing expectation for Medicare Advantage for FY2025
“just over 5%”
Medicare Advantage medical cost trend accele… for FY2026
“nearly 10%”
Optum Health Operating Earnings for FY2025
“$3,000 - $3,100”
Optum Insight Operating Earnings for FY2025
“$3,550 - $3,650”
Optum Rx Operating Earnings for FY2025
“$6,000 - $6,100”
Optum Eliminations Revenues for FY2025
“($5,100)”
Total Optum Operating Margin for FY2025
“4.7% - 4.8%”
Optum Health Fully Accountable Value-Based C… for FY2025
“5 million”
Optum Insight contract revenue backlog for FY2025
“$32.0 billion”
Optum Rx adjusted scripts for FY2025
“1.67 billion”
Optum Health revenues for FY2025
“$101.1 billion to $101.6 billion”
Optum Health earnings from operations for FY2025
“$3.0 billion to $3.1 billion”
Optum Health operating earnings margin for FY2025
“3.0% to 3.1%”
Optum Health patients served under fully acc… for FY2025
“~300,000 to 5 million”
Optum Insight revenues for FY2025
“$19.0 billion to $19.5 billion”
Optum Insight earnings from operations for FY2025
“$3.55 billion to $3.65 billion”
Optum Insight operating earnings margin for FY2025
“18.2% to 19.2%”
Optum Rx revenues for FY2025
“$151.0 billion to $151.5 billion”
Optum Rx earnings from operations for FY2025
“$6.0 billion to $6.1 billion”
Optum Rx operating margin for FY2025
“4.0%”
Revenues - UnitedHealthcare for FY2025
“344,000 - 345,500”
Revenues - Eliminations for FY2025
“(164,500) - (165,000)”
Total consolidated revenue for FY2025
“$445,500 - $448,000”
Earnings from operations - Optum for FY2025
“$12,550 - $12,850”
Total Optum Operating Earnings for FY2025
“$12,550 - $12,850”
Earnings from operations - UnitedHealthcare for FY2025
“9,000 - 9,300”
Total UnitedHealth Group - Operating Earnings for FY2025
“$21,550 - $22,150”
Investment and other income for FY2025
“~$4,400”
Interest expense for FY2025
“~$4,200”
Depreciation and amortization for FY2025
“~$4,300”
Net earnings attributable to UnitedHealth Gr… for FY2025
“At least $13,350”
Diluted weighted-average shares outstanding for FY2025
“912 - 914”
Operating margin for FY2025
“4.8% - 5.0%”
Tax rate for FY2025
“~18.5%”
Cash flows from operations for FY2025
“~$16,000”
Exhibit 99.1 · the passage around this item
… earlier in the release
Today, UnitedHealth Group is updating its 2025 outlook, including revenues of $445.5 billion to $448.0 billion, net earnings of at least $14.65 per share and adjusted earnings of at least $16.00 per share. The new outlook reflects first half 2025 performance and expectations for the remainder of the year, including higher realized and anticipated care trends. The company expects to return to earnings growth in 2026. Outlook components include: UnitedHealth Group 2025 Outlook ( $ in millions, except per share data ) Revenue Operating Earnings Optum $266,000 - $267,500 $12,550 - $12,850 UnitedHealthcare $344,000 - $345,500 $9,000 - $9,300 Eliminations ($164,500) - ($165,000) — Total UnitedHealth Group $445,500 - $448,000 $21,550 - $22,150 Diluted Adjusted (a) Net Earnings per Share At least $14.65 At least $16.00 (a) See page 15 of this release for a reconciliation of the non-GAAP measure. Additional 2025 outlook tables can be found on pages 3, 5 and 9 of this release. The company will provide additional details regarding current and planned actions on a teleconference for analysts and investors today at 8 a.m. ET. Page 1 of 16 Quarterly Financial Performance Three Months Ended June 30, June 30, March 31 2025 2024 2025 Revenues $111.6 billion $98.9 billion $109.6 billion Earnings from Operations $5.2 billion $7.9 billion $9.1 billion Net Margin 3.1% 4.3% 5.7% • UnitedHealth Group’s second quarter 2025 revenues grew $12.8 billion year-over-year to $111.6 billion, driven by growth within UnitedHealthcare and Optum. • Second quarter earnings from operations were $5.2 billion and adjusted
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.